Meridian Pharma PLC

CIF-00062 · U75061US2014PLC100062 · Construction · SME · USA

Back
RM: Mia Rodriguez
Credit Risk Manager: Harper Davis
Exposure: $6.85M
CBRB: Normal
Internal: Normal
Risk Score:34 · Medium
Total Exposure
$6.85M
Prev: $6.96M1.5%
Utilization
26.1%
Prev: 31.3%5.2pp
Banking Relationships
5
Prev: 50.0
CBRB Rating
Normal
Prev: OLEM
Internal Rating
Normal
Prev: Normal
Open Alerts
1
C 0
H 0
M 0
L 1

Exposure Trend Analysis · 24 Months

Funded · Non-Funded · Total

Utilization Trend · Reporting Bank vs Other Banks

Threshold 70%

Rating Migration Timeline

2024-07
OLEM
Start
2026-05
Normal
Upgrade

Banking Relationship Trend · Number of Banks (CBRB)

Increase Decrease No Change

Alert History · 2

DateAlert TypeSeverityDescriptionStatusAssigned ToResolved
3/30/2026Exposure ReductionLowSystem-wide exposure declined materially over the prior month.
Open
David Wilson
3/15/2026Increase in Number of BanksLowBorrower has expanded banking relationships per CBRB data.
Dismissed
Joseph Jackson

AI Risk Score

34
/ 100
Medium Risk
Low
0-30
Med
31-60
High
61-80
Crit
81-100

Risk Driver Analysis

CBRB Rating Migration+15
Banking Relationship Growth+15
Industry Concentration+10
Utilization Level+7
Exposure Growth Trend+5
Internal Rating Drift+5

AI Risk Commentary

AI
Customer exposure decreased by 1.5% month-over-month, currently at $6.85M. Banking relationships moved from 5 to 5 banks per CBRB data. CBRB rating improved from OLEM to Normal. Current utilization is 26.1%. Overall borrower risk is assessed as medium.

Recommended Actions

Review Credit Facility Structure
High
Schedule Customer Meeting
Medium
Reassess Collateral Coverage
Medium
Escalate to Credit Committee
Low
Initiate Monthly Monitoring
Medium

Relationship Team

Relationship Manager
Mia Rodriguez
mia.rodriguez@bank.com
+1 555 0132
Portfolio: $2.26B
Credit Risk Manager
Harper Davis
harper.davis@bank.com
+1 555 0220
Portfolio: $2.09B
Business Head
James Smith
james.smith@bank.com
+1 555 0011
Portfolio: $2.05B
MonthFundedNon-FundedTotalUtilizationBanksRating
2026-06$3.91M$2.95M$6.85M26.1%5Normal
2026-05$3.91M$3.05M$6.96M31.3%5Normal
2026-04$4.24M$2.72M$6.96M35.3%5OLEM
2026-03$4.45M$2.20M$6.65M40.3%5OLEM
2026-02$3.63M$2.93M$6.56M41.0%5OLEM
2026-01$4.19M$2.21M$6.40M35.6%5OLEM
2025-12$3.65M$2.59M$6.24M41.5%5OLEM
2025-11$3.34M$2.82M$6.16M40.2%5OLEM
2025-10$3.81M$2.18M$6.00M39.8%5OLEM
2025-09$3.91M$2.33M$6.25M43.0%5OLEM
2025-08$3.28M$2.65M$5.93M39.9%5OLEM
2025-07$3.46M$2.58M$6.04M39.5%5OLEM